Latest Transplantation medicine Stories

DENVER, Oct. 26, 2012 /PRNewswire/ -- Donor Alliance, the federally-designated, non-profit organ procurement organization and American Association of Tissue Banks (AATB) accredited tissue bank serving Colorado and most of Wyoming, today announced its receipt of the Foothills Award from Rocky Mountain Performance Excellence (RMPEx), a nonprofit helping organizations improve performance and achieve results. RMPEx is a program dedicated to enabling organizations to evolve and succeed...

LADERA RANCH, Calif., Oct. 25, 2012 /PRNewswire/ -- Advanced Biologics announced today that is has validated the OsteoAMP process showing no clinically relevant 'donor to donor' variation. The OsteoAMP® validation used >100 consecutive allograft donors that were processed into products which resulted in 100% clinical success in >300 lumbar and cervical spine fusions. Clinical success was determined by fusion rates radiologically assessed via x-ray and CT by a blinded,...

JERUSALEM, Oct. 24, 2012 /PRNewswire/ -- Hadasit Bio-Holdings Ltd. (TASE: HDST, OTC: HADSY), a publicly traded portfolio of biotech companies, all based on intellectual property developed and owned by Hadassah University Hospital, Israel's foremost medical research center, today announced that its portfolio company Enlivex has completed a clinical trial and is reporting positive results that indicate efficacy and safety in its treatment for recipients of bone marrow transplants from...

Largest living donor kidney transplant program in the country reaches milestone CHICAGO, Oct. 23, 2012 /PRNewswire-USNewswire/ -- Northwestern Medicine® transplant surgeons and physicians have reached a significant milestone with the completion of the 100th successful kidney paired donation transplant, a strategy which has enlarged the pool of kidneys available for donation for patients with a living donor who is not compatible. "We are proud of this accomplishment and our...

BRIDGEWATER, N.J. and HIGHLAND PARK, Ill., Oct. 23, 2012 /PRNewswire/ -- Sanofi Oncology and BMT InfoNet are joining forces to inform patients and the public about the importance of stem cell transplants in the treatment of blood cancers. (Logo: http://photos.prnewswire.com/prnh/20110616/NY20158LOGO ) To view the multimedia assets, please click: http://www.multimedianewscenter.com/sanofi/stem-cell-transplants-awareness-campaign. Approximately every four minutes, one person in...

redOrbit Staff & Wire Reports - Your Universe Online The doctor who is recognized as the father of bone marrow transplantation died Saturday at the age of 92. E. Donnall Thomas, who was awarded the Nobel Prize in 1990 for his work, had been suffering from cardiovascular disease, according to Associated Press (AP) reporter Steven Dubois. His passing was announced by a spokesman at the Fred Hutchinson Cancer Research Center in Seattle. "Thomas' work is among the greatest success...

SEATTLE, Oct. 20, 2012 /PRNewswire/ -- E. Donnall Thomas, M.D., who won the 1990 Nobel Prize in physiology or medicine for his pioneering work in bone-marrow transplantation to cure leukemias and other blood cancers, died today. He was 92. Thomas joined the faculty of Fred Hutchinson Cancer Research Center in 1974 as its first director of medical oncology. He later became associate director and eventually director of the Center's Clinical Research Division. He stepped down...

HORSHOLM, Denmark, Oct. 10, 2012 /PRNewswire/ -- Veloxis will give two upcoming data presentations that further define the profile of LCP-Tacro compared to other tacrolimus formulations. The first study demonstrates the potentially flexible dosing that may improve dosing convenience for transplant patients. A second study demonstrates the enhanced bioavailability of tacrolimus driven by LCP-Tacro's proprietary formulation, compared to another once-daily tacrolimus formulation, which...

HORSHOLM, Denmark, Oct. 5, 2012 /PRNewswire/ -- Veloxis Pharmaceuticals A/S (OMX: VELO) today announced that it has entered into an exclusive distribution agreement with Chiesi Farmaceutici S.p.A, a fully integrated European Pharmaceutical company focused on respiratory disease and special care products, for the commercialization and distribution of its novel formulation immunosuppressant drug candidate LCP-Tacro in certain countries, including Europe, Turkey and CIS countries....

Wolverines for Life kicks off annual challenges against Ohio State for blood donation, organ donor registry ANN ARBOR, Mich., Oct. 3, 2012 /PRNewswire-USNewswire/ -- What would you say to someone who saved your life? In an inspirational new video, U-M patients say thank you to the donors who provided blood, bone marrow, organs and tissues. The video "Choose to be a donor, choose to save a life" is the cornerstone of this fall's Wolverines for Life campaign that includes a massive...